BioCentury
ARTICLE | Clinical News

BL-8020: Phase I/II start

March 18, 2013 7:00 AM UTC

Next month, BioLineRx will begin an open-label, French Phase I/II trial to evaluate BL-8020 in patients who failed or relapsed following standard-of-care treatment. BioLineRx has exclusive, worldwide ...